Reactive oxygen species (ROS) are a significant pathogenic factor of osteoporosis. Ginsenoside-Rb 2 (Rb 2 ), a 20(S)-protopanaxadiol glycoside extracted from ginseng, is a potent antioxidant that generates interest regarding the bone metabolism area. We tested the potential anti-osteoporosis effects of Rb 2 and its underlying mechanism in this study. We produced an oxidative damage model induced by hydrogen peroxide (H 2 O 2 ) in osteoblastic MC3T3-E1 cells to test the essential anti-osteoporosis effects of Rb 2 in vitro. The results indicated that treatment of 0.1 to 10 μM Rb 2 promoted the proliferation of MC3T3-E1 cells, improved alkaline phosphatase (ALP) expression, elevated calcium mineralization and mRNA expressions of Alp, Col1a1, osteocalcin (Ocn) and osteopontin (Opn) against oxidative damage induced by H 2 O 2 . Importantly, Rb 2 reduced the expression levels of receptor activator of nuclear factor kappa-B ligand (RANKL) and IL-6 and inhibited the H 2 O 2 -induced production of ROS. The in vivo study indicated that the Rb 2 administered for 12 weeks partially decreased blood malondialdehyde (MDA) activity and elevated the activity of reduced glutathione (GSH) in ovariectomized (OVX) mice. Moreover, Rb 2 improved the micro-architecture of trabecular bones and increased bone mineral density (BMD) of the 4th lumbar vertebrae (L4) and the distal femur. Altogether, these results demonstrated that the potential anti-osteoporosis effects of Rb 2 were linked to a reduction of oxidative damage and bone-resorbing cytokines, which suggests that Rb 2 might be effective in preventing and alleviating osteoporosis. 
Introduction
Oxidative stress is described as an imbalance between an overproduction of reactive oxygen species (ROS) and an insufficient defense of antioxidants [1] . Oxidative stress can lead to oxidative damage that affects all of the cellular components, including proteins, lipids and nucleic acids. Osteoporosis is defined as a systemic degenerative disease, which is characterized by decreased bone mass and progressive bone micro-architectural deterioration and results in increasing bone fragility and susceptibility to fractures [2] . Currently, many studies have demonstrated a relationship between oxidative damage and osteoporosis or aging. Sendur and colleagues found that the decreased BMD of postmenopausal osteoporotic women was related to higher oxidation of plasma lipid [3] and lowered superoxide dismutase (SOD), catalase and glutathione peroxidase efficacy [4] [5] [6] . Ovariectomy has been shown to induce oxidative damage and to decrease the efficacy of antioxidant defense mechanisms, thus leading to osteoporosis. The activities of lipid peroxidation and H 2 O 2 were increased, and enzymatic antioxidants, such as superoxide dismutase, glutathione peroxidase, and glutathione S transferase, were decreased in ovariectomized animals [7] . Moreover, many studies have demonstrated that superoxide and H 2 O 2 were highly deleterious to cell survival and that they played a major causative role in the aging process [8] . These research findings provided a paradigm shift of osteoporosis pathogenesis from the "estrogen-centric" concept to one in which age-related mechanisms intrinsic to bone and oxidative stress were protagonists. Moreover, the age-related changes in other organs and tissues, such as the ovaries, accentuated these alterations [9] .
Bone remodeling is a process that occurs throughout one's entire life and involves two types of cells: osteogenic cells and monocyte-derived osteoclasts [10] [11] [12] . The osteogenic cells participate in bone formation, and osteoclasts are responsible for bone resorption [13, 14] . The balance between bone formation and bone resorption is essential for maintaining bone homeostasis. Bone turnover changes significantly in postmenopausal osteoporosis: bone resorption is maintained or increases, but bone formation decreases, thereby leading to a net bone loss [15] .
Emerging evidence has shown that ROS increased bone resorption by enhancing osteoclastic development and activity [16] . Indeed, in vivo bone resorption occurs preferentially in sites where ROS and hence oxidative stress levels are high [17, 18] . ROS also led to osteoblast apoptosis, as well as reducing their activity, which led to decreased osteogenesis [19] . Oxidative stress decreases the life span of osteoblast in the bone, as highlighted by the observation that the administration of antioxidants abrogates osteoblast apoptosis in ovariectomized or aged mice [20, 21] . Therefore, we recommend substances that contain antioxidants because they may ameliorate the dysfunction of these two cell types by maintaining bone hemostasis. This suggestion might be implemented by acting as a latent method for the prevention and new treatment for osteoporosis or other related bone metabolic diseases.
Because of fewer side-effects and longer term usage than Western medicine, traditional Chinese medicines with anti-oxidative properties have recently attracted more attention. The ginseng root, which is a highly effective phyto medicinal remedy, is a well-recognized, traditional Chinese medicine that is widely used. The primary components found in ginseng are ginsenosides, which contribute to the most active properties. Ginsenoside-Rb 2 ( Fig. 1) is the most quantitative saponin that is contained in Panax ginseng [22] . It was reported that Rb 2 possessed anti-diabetic, anti-adipocyte, anti-carcinogenic and anti-oxidative properties [23] [24] [25] [26] . More importantly, recent studies showed that H 2 O 2 , which is known as a cancer promoter, inhibited the gap junctional intercellular communication (GJIC) of epithelial cells. Rb 2 supplementation might inhibit the occurrence of cancer through the up-regulation of GJIC in the cancer-accelerating phase [27] . SOD1 is considered to be one of the antioxidant enzymes. A previous study [28] has shown that ginsenoside-Rb 2 could induce the transcriptional expressions of Cu, Zn-superoxide dismutase gene (SOD1). The mutated AP2 binding site in the promoter of SOD1 gene abrogated this effect, which suggests that the SOD1 gene was highly activated by ginsenoside-Rb 2 through the AP2 binding site [28] . Kang et al. studied the hydroxyl radical (•OH) clearing capacity change of Rb 2 through heat procedure using an electron spin resonance spectrometer. Specially, ginsenoside-Rb 2 was heat processed using the same amount of glycine, which was an amino acid commonly employed in the Maillard response model system [26] .
Whether ginsenoside-Rb 2 might provide the potential antiosteoporosis effects and whether these effects are produced by reducing oxidative damage and bone-resorbing cytokines have not been established. Therefore, in the present study, we tested the antiosteoporosis effects of Rb 2 and the underlying mechanisms in vitro and in vivo using an H 2 O 2 -induced oxidative damage model of osteoblastic MC3T3-E1 cells and a murine ovariectomized model.
Materials and methods

Materials
Rb 2 extracted from ginseng (molecular weight, 1079; purity, N98.0%; dissolved in distilled water) was purchased from Shanghai Tauto Biotech Co., LTD (China). The culture flasks and plates were obtained from Nunc (Denmark). The ALP activity assay kit was obtained from GENMED Scientific Inc. (USA). RANKL and IL-6 ELISA assay kits were obtained from R&D system Inc. (Minneapolis, MN, USA) . The total RNA kit was obtained from OMEGA. Prime Script RT reagent kit and SYBR Premix Ex Taq were obtained from TaKaRa Biotechnology (Dalian, China). The oligonucleotide primers were synthesized by TaKaRa Biotechnology. BCIP/NBT alkaline phosphatase color development kit was obtained from Gibco Life Technologies (Grand Island, USA). The reactive oxygen species assay kit, GSH and MDA assay kits were obtained from the Beyotime Institute of Biotechnology (Shanghai, China). All other reagents were of analytical grade.
Cell cultures
Murine MC3T3-E1 cells were purchased from the Center Laboratory for Tissue Engineering, College of Stomatology, Fourth Military Medical University, Xi'an, China [29, 30] . The cells were cultured in α-MEM using 10% heat-inactivated FBS and 100 U/ml penicillin and 100 mg/ml streptomycin in a condition of 5% CO 2 and 37°C. H 2 O 2 acted as exogenous ROS treatment, whereas N-acetyl-L-cysteine (NAC) acted as an ROS cleaner. When the cells reached confluence, the serum-free medium containing Rb 2 was dissolved in distilled water and cultured for 24 h before the administration of 0.3 mM H 2 O 2 for 24 h. For each experiment, Rb 2 administration continued after the pretreatment. All of the experiments were performed in duplicate wells and repeated three times.
Assays of cell survival
For this experiment, the murine MC3T3-E1 cells were administered using different consistencies of Rb 2 (0 μM, 0.1 μM, 1 μM, and 10 μM) for 24 h and 72 h to test the toxicity of Rb 2 . Subsequently, the cells were incubated using the serum-free regular culture medium, which contained Rb 2 (0 μM, 0.1 μM, 1 μM, and 10 μM) for 24 h followed by the administration of 300 μM H 2 O 2 for 24 h. The MTT assays were used for measuring cell survival. The absorbances of all of the wells were recorded using a micro-plate reader at 492 nm wavelength. The cell survival of the control group, which was not exposed to either H 2 O 2 or Rb 2 , was defined as 100%.
Alkaline phosphatase (ALP) staining and activity assay After a 6-day osteogenic induction, the murine MC3T3-E1 cells were incubated using serum-free medium, which contained Rb 2 and/or H 2 O 2 for 2 days. The cells were stained using the BCIP/NBT alkaline phosphatase color development kit according to the manufacturer's instructions. To evaluate the ALP activity, the cell monolayer was lysed using the cell lysis buffer. Subsequently, the lysate was centrifuged at 10,000 g for 5 min. The clear supernatant was used to measure the ALP activity, which was determined employing the ALP activity assay kit. The total protein consistencies were determined using the Bradford protein assay method. The ALP activity was normalized to total protein, which was measured using the Bradford protein assay method.
Calcium mineralization assay
After a 21-day osteogenic induction, the murine MC3T3-E1 cells were incubated using a serum-free medium, which contained Rb 2 and/or H 2 O 2 for 2 days. After the cells were collected, the cells were fixed with formalin for 20 min and stained with Alizarin Red S for 45 min under room temperature. To measure matrix calcification, unbound alizarin red was washed off using PBS. Subsequently, the stain was solubilized using 10% cetylpyridinium chloride by shaking for 15 min. The absorbances of the released Alizarin Red S were recorded using a micro-plate reader at 562 nm wavelength.
Quantitative real-time PCR
After a 6-day osteogenic induction, murine MC3T3-E1 cells were incubated using a serum-free medium, which contained Rb 2 and/or H 2 O 2 for 2 days. The total cellular RNA was extracted from these cells using Trizol reagent. Single strand cDNA synthesis was determined using the Prime Script RT reagent kit (TaKaRa). The RT-PCR was performed using the CFX96 (BIO-RAD) instrument, and individual PCRs were conducted in 96-well optical reaction plates using SYBR Green-I (TaKaRa) according to the manufacturer's instructions. Target gene (Alp, Col1a1, Ocn and Opn) expressions were normalized to the reference gene β-actin. The 2 −ΔΔCt method was applied to calculate the relative gene expression. These PCR products were subjected to a melting curve analysis and a standard curve to confirm the correct amplification. All of the PCRs were performed in triplicate, and the primers used for PCR are shown in Table 1 .
RANKL and IL-6 measurements
After a 6-day osteogenic induction, the murine MC3T3-E1 cells were incubated using serum-free medium, which contained Rb 2 and/or H 2 O 2 for 2 days. The expressions of RANKL and IL-6 in culture medium were tested using the sandwich ELISA assay kit according to the manufacturer's instructions. The total protein consistencies were measured using the Bradford protein assay method.
Intracellular reactive oxygen species (ROS) measurement
After a 6-day osteogenic induction, the murine MC3T3-E1 cells were incubated using serum-free medium, which contained Rb 2 and/or H 2 O 2 for 2 days. The intracellular ROS expression level was determined using the ROS assay kit. DCFH-DA can be oxidized by ROS in viable cells to 2′,7′-dichlorofluorescein (DCF), which is highly fluorescent at 530 nm. These cells were washed three times with PBS. DCFH-DA, which was diluted to a final consistency of 10 μM, was added and cultured for 30 min at 37°C in the dark. When washed three times by PBS, the relative expression of fluorescence was quantified using a multi-detection micro-plate reader (485 nm excitation and 535 nm emission).
Animals and ginsenoside-Rb 2 intervention
Forty 8-week-old, BALB/c female mice, weighing 20.84 ± 1.21 g, were obtained from the Experimental Animal Center of The Fourth Military Medical University (Xi'an, China). There was no significant difference in the initial body weights of the mice among all 4 groups in this experiment. The mice were allowed to adapt to the laboratory environment (a well-ventilated controlled room at 20°C on a 12-h light/dark cycle; the animals were given free access to water and food) for 1 week before the surgery. Subsequently, the mice experienced sham-operation (n = 10) or were surgically ovariectomized (OVX) (n = 30) under anesthesia using pentobarbital sodium (50 mg/kg body weight, i.p.). The ovariectomy operation was performed according to Steven K. Boyd's procedure [31] . A total of 30 BALB/c female mice were randomly divided into three groups: 1) OVX group, administered intraperitoneally with distilled water (n = 10); 2) OVX group, administered intraperitoneally with Rb 2 (body weight, 4.6 μmol/kg; n = 10) daily; and 3) OVX group, administered intraperitoneally with Rb 2 (body weight, 18.5 μmol/kg; n = 10) daily. Rb 2 was dissolved in distilled water. One week after the operation, the treatments commenced and continued for 12 weeks. Blood samples were obtained from the hearts in anesthetized mice and serum samples were prepared by centrifugation. The left femurs and 4th lumbar vertebrae (L4) of the mice were collected and the adherent tissue was discarded. All of the experimental procedures were officially approval by the Ethics in the Animal Research Committee of the Fourth Military Medical University (permission code 2010C00843).
Measurements of serum malondialdehyde (MDA) and reduced glutathione (GSH)
The activity of MDA in whole blood samples was determined using a lipid peroxidation MDA assay kit according to the manufacturer's instructions. The binding of thiobarbituric acid to malondialdehyde, which was formed during lipid peroxidation, results in a chromogenic complex. In the spectrophotometer, the change of absorption peak was detected at 532 nm. Colorimetry was used to detect the Table 1 Real-time PCR primers for amplification of specific MC3T3-E1 mRNA.
Gene
Forward (5′-3′) Reverse (5′-3′) malondialdehyde activity in the whole blood samples. Additionally, the activity of GSH was determined using the GSH assay kit. The GSH activity was determined by the reaction of GSH with 5.50-dithiobis-2-nitrobenzoic acid (DTNB) to produce a product that could be measured using a spectrophotometer at 412 nm.
Assessment of bone micro-architecture and bone mass by micro-computed tomography
The 4th lumbar vertebrae (L4) and the distal femur were scanned using explore Locus SP Pre-Clinical Specimen micro-CT (GE Healthcare, USA) with 8-mm resolution, 50-kV tube voltage and 0.1-mA tube current. The reconstruction and 3D quantitative analyses were determined using software provided by a desktop micro-CT system (GE Healthcare, USA). Similar settings for scans and analyses were used for all of the samples. In the femur, the scanning regions were confined to the distal metaphysis, extending proximally 2.0 mm from the proximal tip of the primary spongiosa. The trabecular bone region from the vertebral body was outlined for each micro-CT slice, excluding both the cranial and caudal endplate regions. The following 3D indices in the defined region of interest (ROI) were analyzed: bone mineral density (BMD), connectivity density (Conn.D), structure model index (SMI), trabecular number (Tb.N), trabecular thickness (Tb.Th), trabecular separation (Tb.Sp) and relative bone volume over total volume (BV/TV, %). The operator who conducted the scan analysis was blinded to the procedure associated with the specimens.
Histological examination by Van Gieson (VG) staining
The 4th lumbar vertebrae and the left femur of all of the mice were collected and fixed in 4% paraformaldehyde for 48 h. After dehydration and embedding, the 4th lumbar vertebrae and the distal femur were embedded in polymethyl-methacrylate (PMMA) and processed into 240-mm-thick sections in the coronal plane using a rotation microtome. Subsequently, all of the sections were hand-grounded to a thickness of 20 mm for VG staining, which was used for staining collagen fiber [32] .
Statistical analysis
The data represented the mean ± SD values of multiple repeats of the same experiment (n = 5). The data for all of the measurements were analyzed using a one-way analysis of variance (ANOVA) with subsequent post hoc multiple comparison by Dunnett's test. Statistically significant values were defined as P b 0.05.
Results
Rb 2 inhibited H 2 O 2 -induced cytotoxicity in MC3T3-E1 cells
Before the anti-cytotoxicity effect of Rb 2 was tested, the toxicity of Rb 2 on MC3T3-E1 was observed. The results showed that Rb 2 treatment alone did not affect cell survival at the consistencies tested in this experiment ( Fig. 2A ). Subsequently, we tested the survival of MC3T3-E1 cells to observe the defensive effects by Rb 2 on the repercussion of the cells after H 2 O 2 -induced oxidative damage. We implemented oxidative damage on MC3T3-E1 cells using 0.3 mM H 2 O 2 for 24 h. When different concentrations of Rb 2 (0.1, 1, 10 μM) were administered to MC3T3-E1 cells for 24 h before H 2 O 2 treatment, the viability of the cells increased compared to the group without Rb 2 treatment, which indicates that Rb 2 , in part, inhibited H 2 O 2 -induced cytotoxicity (Fig. 2B) . N-acetyl-Lcysteine represented the positive control, which significantly suppressed cytotoxicity induced by H 2 O 2 at 1 mM.
Protection by Rb 2 on H 2 O 2 -induced dysfunction of MC3T3-E1 cells
We tested the protective effect of Rb 2 on H 2 O 2 -induced dysfunction of MC3T3-E1 cells by evaluating osteoblast differentiation and mineralization with ALP staining, ALP activity and Alizarin Red S staining. Additionally, we detected the expression of osteogenic genes including Alp, Col1a1, Ocn and Opn. Compared with the control group, all markers of osteogenic differentiation, such as ALP expression, calcium deposition and osteogenic genes (Figs. 3 and 4 ), decreased after treatment of H 2 O 2 . However, when we pretreated MC3T3-E1 cells with Rb 2 (0.1 μM, 1 μM, and 10 μM), cellular ALP expression (Fig. 3A) and activity ( Fig. 3B ) increased in a dose-dependent manner. As shown in Fig. 3C and D, Rb 2 (0.1 μM, 1 μM, and 10 μM) exhibited a good recovery effect on calcium deposition, which was suppressed by H 2 O 2 . Furthermore, pretreatment with Rb 2 partially elevated the expression of osteogenic genes compared with the group of H 2 O 2 treated alone (Fig. 4) . Our data indicated that Rb 2 , in part, attenuated H 2 O 2 -induced dysfunction of MC3T3-E1 cells.
Rb 2 inhibited RANKL and IL-6 expression in MC3T3-E1 cells
Osteoblasts always express and secrete several cytokines, which bind to receptors in osteoclasts and affect osteoclast activity in bone remodeling. RANKL and IL-6 are two essential bone-resorbing factors expressed in osteoblasts. After the addition of 0.3 mM H 2 O 2 , the expressions of RANKL and IL-6 increased. However, when pretreated with Rb 2 of 0.1 μM, 1 μM and 10 μM, the elevated expressions of RANKL and IL-6 were, in part, inhibited (Fig. 5) .
Rb 2 inhibited the production of reactive oxygen species induced by H 2 O 2 in MC3T3-E1 cells
To clarify whether the cell-protective capacity of Rb 2 was associated with its antioxidant property, we tested ROS production using a fluorescent probe DCFH-DA. The results in Fig. 6 showed that when MC3T3-E1 cells were treated with 0.3 mM H 2 O 2 , ROS increased. These data indicated that H 2 O 2 stimulated the generation of oxidants and resulted in oxidative stress to MC3T3-E1 cells. However, when pretreated with Rb 2 of different concentrations, ROS production was partially suppressed ( Fig. 6) . These results suggested that the protection by Rb 2 might be related to its antioxidant activity.
Rb 2 inhibited serum oxidative damage of ovariectomized mice
To test whether Rb 2 can inhibit serum oxidative damage caused by estrogen insufficiency, the activities of serum malondialdehyde (MDA) and reduced glutathione (GSH) were observed in ovariectomized mice with or without Rb 2 intervention. The results in Fig. 7 showed that in contrast to the sham-operated group, the activity of MDA in serum increased, whereas the GSH activity in the ovariectomized group decreased. However, Rb 2 treatment partly rescued the serum activities of MDA and GSH.
Rb 2 improved bone mass and bone structure of ovariectomized mice
To evaluate Rb 2 acting on trabecular bone mass and microarchitecture, different concentrations of Rb 2 were supplemented to the ovariectomized (OVX) mice. When all of the mice were collected at 13 weeks after operation, there were no significant differences in body weights of all four groups. The body weights of the shamoperated group, OVX group, OVX + Rb 2 (4.6 μmol/kg) group and OVX + Rb 2 (18.5 μmol/kg) group were 24.26 ± 0.99 g, 24.12 ± 1.06 g, 24.03 ± 1.09 g and 24.07 ± 0.98 g, respectively. The microarchitectures of distal femurs are shown in Fig. 8A and B. The analyses of the trabecular bone of the 4th lumbar vertebrae (L4) and the distal femur showed that ovariectomy reduced bone mass and deteriorated bone micro-architecture, which was indicated through decreases in BMD, Conn.D, Tb.N, Tb.Th and BV/TV (Fig. 8C and D) (P b 0.05). SMI and Tb.Sp exhibited increases that contributed to ovariectomy (P b 0.05), as shown in Fig. 8E and F. However, the treatment of ovariectomized mice with 4.6 μmol/kg or 18.5 μmol/kg Rb 2 , in part, rescued these bone parameters and improved the micro-architecture of the trabecular bone in the 4th lumbar vertebrae and the distal femur. Moreover, we evaluated the changes of bone micro-architecture by VG staining. As shown in Fig. 8G and H, compared with the shamoperated group, the number of trabeculae decreased and the trabecular space became broader in the OVX group. The supplement of Rb 2 reversed these changes by an elevated number of trabecular bone and a reduction of trabecular bone space ( Fig. 8G and H) . These results were consistent with the micro-CT data (Fig. 8A-F) .
Discussion
The reactive oxygen species are highly reactive oxygen free radicals or non-radical molecules, which include hydrogen peroxide (H 2 O 2 ), ) and hydroxyl radical (•OH) [33] . Their overproduction induces oxidative stress. A considerable number of studies indicated that increased oxidative stress was involved in the pathogenesis of osteoporosis caused by estrogen deficiency and aging [34, 35] . Because of good stability and property to pass through cell membranes, hydrogen peroxide is favorable to serve as both an extra-and an intercellular signal [36] . Therefore, an in vitro H 2 O 2 -induced oxidative damage model was used in this study. The study of Zhang et al. showed that the treatment of 0.3 mM H 2 O 2 for 24 h reduced the number of MC3T3-E1 cells to 50% and that 0.3 mM H 2 O 2 was suitable for generating an in vitro oxidative stress model [32] . Therefore, we used 0.3 mM H 2 O 2 for 24 h to make an oxidative damage model in the present study. Our data showed that H 2 O 2 toxicity was reversed to a certain degree by pretreatment with Rb 2 . This study demonstrated that Rb 2 , in part, decreased H 2 O 2 -induced cytotoxicity on MC3T3-E1 cells.
Oxidative damage not only affects osteoblast survival but also has an impact on its differentiation. H 2 O 2 -induced oxidative damage is reported to inhibit osteoblast differentiation in primary murine bone marrow stem cells and to reduce the expression of osteoblast markers in osteoblastic MC3T3-E1 cells [19, 37] . Our study also showed that H 2 O 2 supplement was linked to a reduction of cellular alkaline phosphatase activity, a decrease of calcium mineralization and lowered expressions of osteogenic genes, including Alp, Col1a1, Ocn and Opn, which confirms previous results that cytotoxicity of H 2 O 2 , in part, results in MC3T3-E1 cell dysfunction. Moreover, our data showed that H 2 O 2 -induced inhibition of osteogenic differentiation could be reversed by Rb 2 . Rb 2 alone could not significantly enhance MC3T3-E1 cell survival and osteogenic differentiation within experimented consistencies. Therefore, we speculated that the antioxidant property of Rb 2 contributed to the protective effect. Because Rb 2 improves osteoblastic survival and differentiation against oxidative damage, Rb 2 might become an anti-osteoporosis agent in the bone metabolism area.
Several pathways and cytokines couple the link between osteoblasts and osteoclasts. RANKL and IL-6 are generated by osteoblasts and function as bone-resorbing cytokines by stimulating osteoclast activity. RANKL belongs to the superfamily of tumor necrosis factor [38] . By binding to RANK, RANKL leads to osteoclastic differentiation, prolongs osteoclastic activity and increases bone resorption [11] . Several studies have shown that reactive oxygen species could elevate the expression of RANKL in osteoblasts [39] . IL-6 is also generated by osteoblasts when it is motivated by IL-1, TNF-α, and lipopolysaccharide [40] . IL-6 could affect the expression of RANKL, improve osteoclast development and be a significant pathogenic factor of estrogen deficiency osteoporosis [41, 42] . It was reported that reactive oxygen species might indirectly influence osteoclasts by increasing the expression of bone-resorptive cytokines, which are highly involved in estrogen deficiency osteoporosis [43] . In our study, Rb 2 was noted to inhibit, in part, the H 2 O 2 -induced generations of RANKL and IL-6 in MC3T3-E1 cells. The reductions of RANKL and IL-6 might contribute to the anti-resorbing property, which Rb 2 exhibited.
Ginsenoside-Rb 2 (Rb 2 ), which is extracted from Panax ginseng, belongs to traditional Chinese medicine. Recently, its anti-oxidative property has been reported [16] . In this study, we could reverse, in part, H 2 O 2 -induced production of reactive oxygen species by pretreatment with Rb 2 for 24 h. Our data indicated that Rb 2 might be a useful antioxidant to protect MC3T3-E1 cells from cytotoxicity induced by oxidative damage. Consequently, the protection by Rb 2 to MC3T3-E1 cells could be mediated via its antioxidant property. The beneficial effect of Rb 2 might be linked to reduced oxidative damage and boneresorbing cytokines. However, the molecular mechanism has not been established. Compared with other growth factors, reactive oxygen species result in the retention of FoxOs in the nucleus and the activation of their transcription [44] . FoxO protein family is characterized by a common winged-helix DNA binding domain called Forkhead box [45] . Animal studies have demonstrated that in response to oxidative damage, c-jun kinase (JNK) and mammalian sterile 20-related kinase-1 (Mst1) bond and phosphorylate FoxOs in a direct manner [46] [47] [48] [49] . FoxO-dependent oxidative defense systems provide an approach for dealing with oxygen free radicals that are constantly produced by the aerobic metabolism of osteoblasts and are therefore essential for bone mass balance [50] . Under these circumstances, we deduced that Rb 2 provided protective effects against cytotoxicity and osteoblast dysfunction induced by H 2 O 2 through the JNK, Mst1 and FoxOs signaling pathway. In additional studies, we will explore this molecular mechanism.
The mechanism by which estrogen deficiency activates bone loss has not been established. Recently, oxidative damage has been documented to result in postmenopausal osteoporosis. Almeida et al. reported that similar increases in oxidative stress and p66 shc phosphorylation observed with age-related changes in bone of C57BL/6 mice were caused by removing gonads in the female or male mice [17, 20] . Moreover, the alterations were ameliorated by administering antioxidants, such as N-acetyl-L-cysteine, ascorbate, and catalase, which is as effective as hormone replacement [9] . Malondialdehyde (MDA), which commonly served as a trustful parameter in evaluating the oxidative damage status [51] , is an end product of lipid peroxidation induced by reactive oxygen species. . Additionally, GSH reduction is a marker of oxidative damage [53] . Our research showed that Rb 2 administration for 12 weeks reversed, in part, serum MDA and GSH activities of ovariectomized mice. Sharing similarities with postmenopausal women, ovariectomized mice experience significant bone loss due to estrogen deficiency, which primarily results from trabecular bone loss [54] . Therefore, the trabecular bone micro-architecture is considered to be a proper predictor of OVX-induced bone loss and bone quality deterioration [55] . The micro-architecture of trabecular bone has been shown to dramatically deteriorate after ovariectomy by both micro-CT scanning and VG staining [32, 56] . Nevertheless, these negative effects could be reversed, to some degree, after administering Rb 2 . These results further confirmed that Rb 2 might, in part, ameliorate trabecular micro-architecture and bone mass of OVX mice and that Rb 2 might be a good candidate for the prevention and the treatment of estrogendeficient osteoporosis.
To conclude, the results described in this article indicated that in an in vitro analysis, ginsenoside-Rb 2 protected osteoblastic MC3T3-E1 cells from cytotoxicity and osteoblast dysfunction induced by hydrogen peroxide at 0.1 to 10 μM. This activity is linked to a reduction of oxidative damage and bone-resorbing cytokines. More importantly, ginsenoside-Rb 2 decreased serum reactive oxygen species to a certain degree and partly reversed estrogen-deficient effects in vivo at doses of 4 to 18 μmol/kg body weight. Ginsenoside-Rb 2 may act as a substantive alternative in bone metabolic diseases, especially osteoporosis. Extensive research is needed in the future to explore the intricate molecular mechanisms of ginsenoside-Rb 2 on bone metabolism. 
